No takes yet. Share an insight, caveat, or question.
Randomized trial evaluates flare risk in rheumatoid arthritis patients with DMARD dose optimization, highlighting personalized treatment implications.
Blanco et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: